The evolution of cardiopulmonary bypass: Lessons to be learned

Perfusion

Volumn 17, Issue 4, 2002, Pages 243-251

  Edmunds Jr , L Henry ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APROTININ; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; DISINTEGRIN; EPTIFIBATIDE; FIBRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; KALLIKREIN; OXYGEN; PROTAMINE; THROMBIN; PLASMA PROTEIN;

ARTICLE; ARTIFICIAL ORGAN; BLOOD; CARDIOPULMONARY BYPASS; CELL SURFACE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOTHELIUM CELL; EXPOSURE; EXTRACORPOREAL CIRCULATION; HUMAN; INFLAMMATION; MEDICAL TECHNOLOGY; NONHUMAN; OPEN HEART SURGERY; OXYGENATOR; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL EQUIPMENT; THROMBOGENICITY; THROMBOSIS; BLOOD CLOTTING; CARDIOLOGY; DRUG EFFECT; HISTORY; INSTRUMENTATION; METABOLISM; REVIEW; UNITED STATES;

BLOOD COAGULATION; BLOOD PROTEINS; CARDIOLOGY; CARDIOPULMONARY BYPASS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; OXYGENATORS, MEMBRANE; UNITED STATES;

EID: 0036317037     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659102pf585oa     Document Type: Article

References (58)

1. Ben Franklin and open heart surgery
2. The thromboplastic action of cephalin
3. Addendum: The discovery of heparin
4. Neutralization of action of heparin by protamine
5. The development of the heart-lung apparatus
6. The maintenance of life during experimental occlusion of the pulmonary artery followed by survival
7. The application of a mechanical heart and lung apparatus to cardiac surgery
8. Historical development of cardiopulmonary bypass in Minnesota
9. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (Gibbon type): Report of eight cases
10. A report on the use of both extracorporeal circulation and hypothermia for open heart surgery
11. Cardiac arrest of one hour duration in dogs during hypothermia of 0°C followed by survival
12. Profound hypothermia in cardiac surgery
13. Profound hypothermia combined with extracorporeal circulation for open heart surgery
14. Doublehelical reservoir heart-lung machine
15. The birth of an idea and the development of cardiopulmonary bypass
16. An improved vertical cylinder oxygenator
17. A simple, expendable, artificial oxygenator for open heart surgery
18. Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations
19. Fat globulinemia in extracorporeal circulation
20. Neuropathological manifestations of cardiac surgery
21. The production of microemboli by various oxygenators
22. Cardiopulmonary bypass, microembolization and platelet aggregation
23. Prolonged cardiopulmonary support with a practical membrane oxygenator
24. Design and performance of a new membrane lung
25. Construction and evaluation of an artificial lung
26. Development and evaluation of a new hollow-fiber membrane oxygenator
27. Evaluation of hollow fiber and spiral coil membrane oxygenators for cardiopulmonary bypass in infants
28. The Lande-Edwards membrane oxygenator during heart surgery
29. Platelet aggregate emboli produced in patients during cardiopulmonary bypass with membrane and bubble oxygenators and blood filters
30. Effects of extracorporeal circulation on personality and cerebration
31. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock lung); report of a successful case using the Bramson membrane lung
32. Extracorporeal membrane oxygenation in severe acute respiratory failure: A randomized prospective study
33. Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study
34. Biomaterials in medical devices
35. Initial events in interactions of blood with a foreign surface
36. Blood-surface interface
37. Platelet adhesion induced by fibrinogen adsorbed onto glass
38. Function of human platelets during extracorporeal circulation
39. Platelet anesthesia with nitric oxide with and without eptifibatide during cardiopulmonary bypass in baboons
40. The inflammatory response to cardiopulmonary bypass
41. Coagulation, Anticoagulation, and the interaction of blood and artificial surfaces
42. Blood activation in mechanical circulatory assist devices
43. Complement activation during cardiopulmonary bypass
44. Complement (C5a)-induced granulocyte aggregation in vitro
45. Complement and the damaging effects of cardiopulmonary bypass
46. Formation of C1-C1-inhibitor, kallikrein-C1-inhibitor and plasmin-α2-plasmin-inhibitor complexes during cardiopulmonary bypass
47. Pharmacology and biological efficacy of a recombinant, humanized, singlechain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass
48. Human neutrophil degranulation during extracorporeal circulation
49. Enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery in man is caused by extrinsic (tissue type) plasminogen activator
50. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trysylol)
51. Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant?
52. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass
53. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass
54. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass
55. Tissue factor is expressed on monocytes during simulated extracorporeal circulation
56. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass
57. Plasma tissue factor in combination with mononuclear cells accelerates activation of factor VII in cardiac surgical wounds